日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy

血清分析物作为预测三阴性乳腺癌患者疾病复发和无侵袭性疾病生存期的指标，这些患者均参与了 OXEL 试验，接受了免疫疗法、化疗或化疗联合免疫疗法治疗。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-011379
Toney, Nicole J; Lynch, Megan T; Lynce, Filipa; Mainor, Candace; Isaacs, Claudine; Schlom, Jeffrey; Donahue, Renee N
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

303. PATIENT AND CLINICIAN ACCEPTANCE OF RECENT TECHNOLOGICAL ADVANCES IN THE THERAPEUTIC MONITORING OF LITHIUM

303. 患者和临床医生对锂治疗监测领域最新技术进步的接受度

期刊:Journal of the American Medical Informatics Association
影响因子:4.6
doi:10.1093/jamia/ocae190
Northrop, Anna; Christofferson, Anika; Umashankar, Saumya; Melisko, Michelle; Castillo, Paolo; Brown, Thelma; Heditsian, Diane; Brain, Susie; Simmons, Carol; Hieken, Tina; Ruddy, Kathryn J; Mainor, Candace; Afghahi, Anosheh; Tevis, Sarah; Blaes, Anne; Kang, Irene; Asare, Adam; Esserman, Laura; Hershman, Dawn L; Basu, Amrita; Dodd, S; Pedraza-Sanabria, S; Paredes Castro, A M; Williams, L J; Giraldo-Cadavid, L F; Bustos, R H
发表日期：2025
文献求助 收藏

Best practices for clinical trials data harmonization and sharing on NHLBI bioData catalyst (BDC) learned from CONNECTS network COVID-19 studies

从 CONNECTS 网络 COVID-19 研究中汲取的关于 NHLBI bioData Catalyst (BDC) 临床试验数据协调和共享的最佳实践

期刊:Journal of Clinical and Translational Science
影响因子:2
doi:10.1017/cts.2025.52
Stratford, Jeran K; Pan, Huaqin Helen; Mainor, Alex; Music, Edvin; Froess, Joshua; Cheng, Alex C; Weissman, Alexandra; Huang, David T; Oelsner, Elizabeth C; Thomas, Sonia M
发表日期：2025
文献求助 收藏

The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity

阿司匹林难题——应对负面结果、年龄、衰老动态和公平性

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2024.4828
Mandelblatt, Jeanne S; Mainor, Candace; Hudson, Barry I
衰老
发表日期：2024
文献求助 收藏

Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

作者更正：辅助治疗三阴性乳腺癌残余患者：纳武利尤单抗、卡培他滨或二者联合治疗：OXEL随机II期研究

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-48359-1
Lynce, Filipa; Mainor, Candace; Donahue, Renee N; Geng, Xue; Jones, Greg; Schlam, Ilana; Wang, Hongkun; Toney, Nicole J; Jochems, Caroline; Schlom, Jeffrey; Zeck, Jay; Gallagher, Christopher; Nanda, Rita; Graham, Deena; Stringer-Reasor, Erica M; Denduluri, Neelima; Collins, Julie; Chitalia, Ami; Tiwari, Shruti; Nunes, Raquel; Kaltman, Rebecca; Khoury, Katia; Gatti-Mays, Margaret; Tarantino, Paolo; Tolaney, Sara M; Swain, Sandra M; Pohlmann, Paula; Parsons, Heather A; Isaacs, Claudine
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

辅助治疗中，纳武利尤单抗、卡培他滨或二者联合治疗残留三阴性乳腺癌患者的疗效：OXEL随机II期研究

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-46961-x
Lynce, Filipa; Mainor, Candace; Donahue, Renee N; Geng, Xue; Jones, Greg; Schlam, Ilana; Wang, Hongkun; Toney, Nicole J; Jochems, Caroline; Schlom, Jeffrey; Zeck, Jay; Gallagher, Christopher; Nanda, Rita; Graham, Deena; Stringer-Reasor, Erica M; Denduluri, Neelima; Collins, Julie; Chitalia, Ami; Tiwari, Shruti; Nunes, Raquel; Kaltman, Rebecca; Khoury, Katia; Gatti-Mays, Margaret; Tarantino, Paolo; Tolaney, Sara M; Swain, Sandra M; Pohlmann, Paula; Parsons, Heather A; Isaacs, Claudine
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study

LEANORA 研究：利博西尼在转移性乳腺癌黑人患者中的药代动力学和药物基因组学

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00692-w
Schlam, Ilana; Smith, D Max; Peer, Cody; Sissung, Tristan; Schmidt, Keith T; Tan, Ming; Chitalia, Ami; Bishopric, Nanette H; Steinberg, Seth; Choo-Wosoba, Hyoyoung; Napoli, Giulia; Gallagher, Christopher; Ashai, Nadia; Whitaker, Kristen; Mainor, Candace; Tiwari, Shruti; Swanson, Nicole; Malloy, Stacy; Isaacs, Claudine; Figg, William Douglas; Swain, Sandra M
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Taking AIM at serious illness: implementing an access to investigational medicines expanded access program

瞄准重症：实施扩大试验药物获取途径计划

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1287449
Joly, Meghan Morrison; Edwards, Terri L; Jerome, Rebecca N; Mainor, Alex; Bernard, Gordon R; Pulley, Jill M
发表日期：2023
文献求助 收藏

A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor

一项针对对芳香化酶抑制剂和 CDK4/6 抑制剂耐药的转移性激素受体阳性、HER2 阴性 (HR+ HER2-) 乳腺癌患者的 I 期临床试验，评估了帕博西尼、博舒替尼联合氟维司群的疗效。

期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2023.101110
Roy, Tina; Barrows, Elizabeth; Mainor, Candace; Collins, Julie; Lynce, Filipa; Isaacs, Claudine; Pohlmann, Paula R
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Time course study of Paenarthrobacter nicotinovorans secondary metabolite toxicity profile

食烟酸杆菌次级代谢产物毒性特征的时间过程研究

期刊:microPublication Biology
影响因子:
doi:10.17912/micropub.biology.000922
Justyna Kakol, Mainor Vang, Drew Sausen, Tracey Steeno, Angelo Kolokithas
代谢
发表日期：2023
文献求助 收藏